Screener
Ligand Pharmaceuticals LGND EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Total non-operating income (expenses), net | 55,713 | 2,779 | 14,086 | (11,185) |
| Income (loss) before income taxes | 64,304 | 11,223 | 40,045 | (38,957) |
| Income tax (expense) benefit | (15,796) | (6,376) | (4,882) | 1,353 |
| Net income (loss) | $48,508 | $4,847 | $35,163 | $(37,604) |
| Basic net income (loss) per share | $2.42 | $0.25 | $1.76 | $(1.95) |
| Shares used in basic per share calculation | 20,063 | 19,327 | 19,974 | 19,259 |
| Diluted net income (loss) per share | $2.22 | $0.24 | $1.63 | $(1.95) |
| Shares used in diluted per share calculation | 21,837 | 19,926 | 21,548 | 19,259 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's EPS (diluted)?
- Ligand Pharmaceuticals (LGND) reported EPS (diluted) of $2.22 in Q2 2026.
- How has Ligand Pharmaceuticals's EPS (diluted) changed year-over-year?
- Ligand Pharmaceuticals's EPS (diluted) increased by 825.0% year-over-year, from $0.24 to $2.22.
- What is the long-term trend for Ligand Pharmaceuticals's EPS (diluted)?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's EPS (diluted) has grown at a 14.3% compound annual growth rate (CAGR), from $3.45 to $5.89.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Ligand Pharmaceuticals's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude